Michael A Ruzek, DO | |
200 Trenton Rd, Browns Mills, NJ 08015-1705 | |
(609) 735-5962 | |
Not Available |
Full Name | Michael A Ruzek |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 14 Years |
Location | 200 Trenton Rd, Browns Mills, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275834830 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | OT013602 (Pennsylvania) | Secondary |
207P00000X | Emergency Medicine | P13-00474 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
Cape Fear Valley Medical Center | Fayetteville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Capital Health Multispecialty Group | 1850689894 | 233 |
Cfvhs Ed Physicians | 2961316237 | 27 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.
The liquor industry's decision to voluntarily include health warning labels on alcohol is a welcome move, but alone is unlikely to make a significant impact on the health and social consequences of alcohol abuse and binge drinking in Australia.
Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.
The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.
› Verified 8 days ago
Entity Name | Summit Oaks Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205880200 PECOS PAC ID: 8628047685 Enrollment ID: O20051213000141 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.
The liquor industry's decision to voluntarily include health warning labels on alcohol is a welcome move, but alone is unlikely to make a significant impact on the health and social consequences of alcohol abuse and binge drinking in Australia.
Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.
The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.
› Verified 8 days ago
Entity Name | Union Emergency Medical Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689847352 PECOS PAC ID: 0547334427 Enrollment ID: O20080812000013 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.
The liquor industry's decision to voluntarily include health warning labels on alcohol is a welcome move, but alone is unlikely to make a significant impact on the health and social consequences of alcohol abuse and binge drinking in Australia.
Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.
The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.
› Verified 8 days ago
Entity Name | Capital Health Multispecialty Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083072342 PECOS PAC ID: 1850689894 Enrollment ID: O20161007000162 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.
The liquor industry's decision to voluntarily include health warning labels on alcohol is a welcome move, but alone is unlikely to make a significant impact on the health and social consequences of alcohol abuse and binge drinking in Australia.
Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.
The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.
› Verified 8 days ago
Entity Name | Rwjbh Observation Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760095806 PECOS PAC ID: 5193137503 Enrollment ID: O20201209000008 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.
The liquor industry's decision to voluntarily include health warning labels on alcohol is a welcome move, but alone is unlikely to make a significant impact on the health and social consequences of alcohol abuse and binge drinking in Australia.
Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.
The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.
› Verified 8 days ago
Entity Name | Rwjbh Emergency Medicine Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912510041 PECOS PAC ID: 0941612840 Enrollment ID: O20201217002547 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.
The liquor industry's decision to voluntarily include health warning labels on alcohol is a welcome move, but alone is unlikely to make a significant impact on the health and social consequences of alcohol abuse and binge drinking in Australia.
Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.
The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Michael A Ruzek, DO 803 Rahway Ave, Westfield, NJ 07090-3435 Ph: () - | Michael A Ruzek, DO 200 Trenton Rd, Browns Mills, NJ 08015-1705 Ph: (609) 735-5962 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.
The liquor industry's decision to voluntarily include health warning labels on alcohol is a welcome move, but alone is unlikely to make a significant impact on the health and social consequences of alcohol abuse and binge drinking in Australia.
Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.
The number of patients receiving radiation therapy in the United States for cancer treatment is expected to increase by more than 20 percent over the next decade to almost 600,000 per year. But radiation research over the past decade has decreased substantially, making it more difficult to provide oncologists with the best training in the latest techniques, particularly the integration of medical physics, which is now a required aspect in the clinical practice of radiotherapy.
› Verified 8 days ago
Benjamin Neil Paschkes, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Trenton Rd, Browns Mills, NJ 08015 Phone: 609-621-2074 Fax: 856-824-1403 |